Table 5 Literature evidence for involvement of ‘suggestive’ markers (or gene loci) with p-values of <1.0E-05 in the associated phenotype traits.

From: Genetic risk variants for metabolic traits in Arab populations

Marker/Gene

Phenotype trait

Comments

rs3767494/C1orf106

HbA1c

A systematic analysis of genetic loci of cross autoimmune disorders implicated role of c1orf106 gene in the etiology of Type 1 diabetes72.

rs17117722/[TRA, TRD]

WcHtR

Both the TRA and TRD genes are members of the class of T-Cell receptor proteins. T-cells play an important role in the immune adaptation to both obesity and malnutrition73. T-cells play an early and critical role in inducing inflammation in obesity and in the accumulation of inflammatory macrophages in obese adipose tissue; both these two processes are known to promote insulin resistance.

rs10005556/GAPDHP56

Weight/BMI/Waist Circumference

Genome region of GAPDHP56 (chr4:131448001-131451000, chr4:131449501-131452500) is reported as associated with total fat mass in genome-wide rare variants analysis of UK10K Cohorts52.

rs1184476/TEX29

Weight

Variants of TEX29 (alias C13orf16) are associated with age at menarche among Chinese women. However, as of now there is no report of their role in Weight gain53.

rs9390649/UST

Waist circumference

A study using mice suggests an important role for Uronyl 2-sulfotransferase transfers in clearance of triglyceride-rich lipoprotein74.

rs17639988/MDGA1, ZFAND3

HbA1c

Intergenic SNPs between MDGA1 and ZFAND3 are implicated in T2DM in East Asian population54.

rs17716285/KSR1

HbA1c

Kinase suppressor of Ras 1 (KSR1) is required for Ras-mediated ERK pathway activation. This pathway is identified as modifiers of cellular insulin responsiveness. A study conducted on OLETF rat models for T2DM have shown that suppressing the KSR1/ERK complex brings down diabetic vascular complications51.

rs883431/SLC28A3

FPG

A study in rat indicates upregulation of SLC28A3 in glomerulus in diabetic condition. But till date no human study is reported49.

rs4764409/PIK3C2G

FPG

Variants from this gene are found to be associated with high HbA1c and low serum insulin levels in Japanese T2D population55. PI3K orchestrates its action through AKT2 pathway in the liver, as a main regulator of metabolism75.

rs1800775/CETP

HDL

rs1800775 is a well-known upstream (~2KB) variant of CETP gene shown to be replicated in European population with HDL76.

rs9326246/BUD13

TGL

Extended CARDIoGRAM study (involving participants of European ancestry) implicated rs9326246 marker as associated with TGL and as one of the important CAD susceptibility loci76.

rs925530/TMEM120B

TGL

The role of TMEM120B in fat metabolism has been established in knockdown cell line studies50.

rs17073574/LAMA4

TGL

Studies have shown association of LAMA4 in obesity and diabetic nephropathy77,78.

rs11777524/LY6D, GML

TGL

There is lack of literature reports on the role of GML (Glycosylphosphatidylinositol-anchored molecule like) in processes relating to triglyceride. But there is evidence for GPIHBP1 (Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1) in causing hypertriglyceridemia. Protein sequence comparison analysis shows 28% identity between these two proteins. Furthermore, it is known that GPIHBP1 evolved LY6-like genes79.

rs11602685/MICAL2

TGL

Its association with plasma uric acid in obese individuals is evident. However, it requires more literature support to establish its functional role in elevation of triglyceride levels80.

rs10497520/TTN

SBP

Involvement of the TTN gene in hypertension is substantiated by literature evidences. Rain et al.81 found that phosphorylation of titin in right ventricular tissue was significantly reduced in pulmonary arterial hypertension patients (undergoing heart/lung transplantation) as compared with control subjects. Mutations in this gene are associated with familial hypertrophic cardiomyopathy82. Further, Ottenheijm et al. demonstrated that alternative splicing of the TTN gene was associated with diaphragm dysfunction in patients with mild to moderate chronic obstructive pulmonary disease83.